Frequencies for first 10,000 rows of dose_form variable in drug2014q3 dataset : Form of dose reported | Freq. Percent Cum. ----------------------------------------+----------------------------------- | 7,088 70.88 70.88 AQUEOUS SPRAY | 1 0.01 70.89 CAPLET | 6 0.06 70.95 CAPSULE | 284 2.84 73.79 CAPSULE, HARD | 11 0.11 73.90 CAPSULES | 53 0.53 74.43 CHEWABLE TABLET | 5 0.05 74.48 COATED TABLET | 2 0.02 74.50 CONCENTRATE FOR SOLUTION FOR INFUSION | 148 1.48 75.98 CREAM | 1 0.01 75.99 DISPERSIBLE TABLET | 15 0.15 76.14 DROP | 3 0.03 76.17 DROPS | 5 0.05 76.22 EFFERVESCENT TABLET | 1 0.01 76.23 EXTENDED RELEASE TABLET | 7 0.07 76.30 EYE DROPS | 2 0.02 76.32 EYE DROPS, SOLUTION | 10 0.10 76.42 EYE DROPS, SUSPENSION | 2 0.02 76.44 FAST DISSOLVING TABLET | 3 0.03 76.47 FILM COATED TABLET | 1 0.01 76.48 FILM-COATED TABLET | 102 1.02 77.50 FORMULATION UNKNOWN | 27 0.27 77.77 GASTRO-RESISTANT CAPSULE | 2 0.02 77.79 GEL | 3 0.03 77.82 HFA-CFC FREE INHALER | 2 0.02 77.84 IMPLANT | 1 0.01 77.85 INFUSION | 2 0.02 77.87 INHALATION POWDER | 14 0.14 78.01 INHALATION POWDER, HARD CAPSULE | 4 0.04 78.05 INHALATION SOLUTION | 4 0.04 78.09 INHALATION VAPOUR | 2 0.02 78.11 INHALATION VAPOUR, LIQUID | 1 0.01 78.12 INHALATION VAPOUR, SOLUTION | 1 0.01 78.13 INJECTION | 162 1.62 79.75 INJECTION FOR INFUSION | 9 0.09 79.84 INTRAUTERINE DELIVERY SYSTEM | 16 0.16 80.00 INTRAVENOUS INFUSION | 47 0.47 80.47 INVESTIGATIONAL DOSAGE FORM | 1 0.01 80.48 LIPOSOME INJECTION | 6 0.06 80.54 LIQUID | 5 0.05 80.59 LYOPHILIZED POWDER | 94 0.94 81.53 MODIFIED-RELEASE TABLET | 55 0.55 82.08 MOUTH WASH | 2 0.02 82.10 MULTI DOSE POWDER INHALER | 4 0.04 82.14 NASAL SPRAY | 3 0.03 82.17 NEBULISER LIQUID | 1 0.01 82.18 NEBULISER SUSPENSION | 2 0.02 82.20 ORAL DROPS | 1 0.01 82.21 ORAL DROPS, SOLUTION | 1 0.01 82.22 ORAL DRUG UNSPECIFIED FORM | 13 0.13 82.35 ORAL EMULSION | 1 0.01 82.36 ORAL SOLUTION | 16 0.16 82.52 OROMUCOSAL SPRAY | 1 0.01 82.53 PATCH | 4 0.04 82.57 PILL (EXCEPT TABLETS) | 1 0.01 82.58 POWDER | 1 0.01 82.59 POWDER AND SOLVENT FOR SOLUTION FOR I.. | 6 0.06 82.65 POWDER AND SOLVENT FOR SOLUTION FOR I.. | 20 0.20 82.85 POWDER FOR INJECTION | 4 0.04 82.89 POWDER FOR ORAL SOLUTION | 1 0.01 82.90 POWDER FOR ORAL SUSPENSION | 1 0.01 82.91 POWDER FOR SOLUTION FOR INJECTION | 18 0.18 83.09 PROLONGED-RELEASE CAPSULE | 21 0.21 83.30 PROLONGED-RELEASE TABLET | 116 1.16 84.46 RECTAL SOLUTION | 1 0.01 84.47 SLOW RELEASE TABLET | 1 0.01 84.48 SOLUTION | 1 0.01 84.49 SOLUTION (EXCEPT SYRUP) | 57 0.57 85.06 SOLUTION FOR INFUSION | 14 0.14 85.20 SOLUTION FOR INJECTION | 84 0.84 86.04 SOLUTION FOR INJECTION IN PRE-FILLED .. | 5 0.05 86.09 SOLUTION FOR INJECTION IN PRE-FILLED .. | 38 0.38 86.47 SOLUTION FOR PERITONEAL DIALYSIS | 3 0.03 86.50 SPRAY | 1 0.01 86.51 SUPPOSITORY | 2 0.02 86.53 SUSPENSION | 18 0.18 86.71 SUSPENSION FOR INJECTION | 5 0.05 86.76 SUSTAINED RELEASE TABLETS | 5 0.05 86.81 TABLET | 883 8.83 95.64 TABLET-EXTENDED RELEASE | 1 0.01 95.65 TABLETS | 48 0.48 96.13 TRANSDERMAL PATCH | 5 0.05 96.18 UNK | 12 0.12 96.30 UNKNOWN | 133 1.33 97.63 UNKNOWN FORMULATION | 8 0.08 97.71 UNSPECIFIED | 205 2.05 99.76 UNSPECIFIED INJECTABLE | 1 0.01 99.77 VAGINAL RING | 23 0.23 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 19 Apr 2017